Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 10, Issue Suppl 2
748 A phase 1/2, open-label, dose-escalation, safety and tolerability study of NC762 in subjects with advanced or metastatic solid tumors
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
748 A phase 1/2, open-label, dose-escalation, safety and tolerability study of NC762 in subjects with advanced or metastatic solid tumors
Free
Online download statistics by month:
Online download statistics by month: November 2022 to August 2024
Abstract
Full
Pdf
Nov 2022
164
0
11
Dec 2022
26
0
3
Jan 2023
44
0
3
Feb 2023
72
0
7
Mar 2023
74
0
9
Apr 2023
50
0
2
May 2023
66
0
2
Jun 2023
74
0
7
Jul 2023
36
0
13
Aug 2023
60
0
9
Sep 2023
68
0
4
Oct 2023
368
0
7
Nov 2023
88
0
7
Dec 2023
130
0
8
Jan 2024
52
0
7
Feb 2024
74
0
5
Mar 2024
102
0
10
Apr 2024
44
0
1
May 2024
60
0
8
Jun 2024
42
0
4
Jul 2024
66
0
9
Aug 2024
46
0
6
Total
1806
0
142
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?